BY AND BETWEENProduct Acquisition Agreement • February 7th, 2005 • Barrier Therapeutics Inc • Pharmaceutical preparations • New York
PRODUCT ACQUISITION AGREEMENT by and between VALEANT PHARMACEUTICALS NORTH AMERICA (as buyer) and INTERMUNE, INC. (as seller) November 28, 2005Product Acquisition Agreement • August 8th, 2006 • Intermune Inc • Pharmaceutical preparations • Delaware
This PRODUCT ACQUISITION AGREEMENT (as amended from time to time, the “Agreement”), dated November 28, 2005 (the “Execution Date”), is made and entered into by and between VALEANT PHARMACEUTICALS NORTH AMERICA, a Delaware corporation (the “Buyer”), and INTERMUNE, INC., a Delaware corporation (the “Seller”). Buyer and Seller are sometimes collectively referred to herein as the “Parties” and separately as a “Party.”
AMPHOTEC®/AMPHOCIL® PRODUCT ACQUISITION AGREEMENT BETWEEN ALZA CORPORATION AND INTERMUNE PHARMACEUTICALS, INC.Product Acquisition Agreement • May 15th, 2001 • Intermune Pharmaceuticals Inc • Pharmaceutical preparations • California
This Product Acquisition Agreement (the "Agreement") is made effective as of the 2nd day of January, 2001 between ALZA Corporation ("ALZA"), a Delaware corporation and InterMune Pharmaceuticals, Inc., a Delaware corporation ("InterMune").
